The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales (Q36958072)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2007
edit
Language Label Description Also known as
English
The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales
scientific article published on October 2007

    Statements

    The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit